Logo
Logo
Logo

,

Shanda Portfolio

Turn Biotechnologies Licenses Revolutionary Technology to Unwind the Effects of Aging at a Cellular Level

Turn Biotechnologies, a Shanda VC portfolio company developing medicines for currently untreatable age-related conditions, announced that it has acquired the global rights for new technology that reprograms cells to undo many of the effects of aging.

 

Read more

You might also be interested in

11/28/25

The Twilight of Management and the Dawn of Intelligence: Rewriting the Biological Genes of Enterprises

Tianqiao Chen Shanda Group founder, chairman and CEO Preface: The Dusk of Management Peter Drucker once said that [...]

Shanda in the News

11/24/25

Shanda Group Participates in Cordance Medical’s Oversubscribed $8M Seed Financing to Advance Focused Ultrasound Platform for Brain Disease Treatment

We are excited to join Cordance Medical's oversubscribed $8M seed round led by Sonder Capital, and including, Angel Physicians Fund, [...]

Shanda Portfolio

10/28/25

Serial Entrepreneur Tianqiao Chen Presents Vision for “Discoverative” Intelligence at AIAS2025 (www.aias2025.org)

San Francisco, CA, October 28th - Serial entrepreneur and philanthropist Tianqiao Chen today announced a $1 billion commitment to revolutionize artificial [...]

Shanda Announcements